About Childhood-onset stress-induced neurodegenerative ataxia-seizure syndrome
Childhood-onset stress-induced neurodegenerative ataxia-seizure syndrome is a rare disease catalogued by Orphanet (ORPHA:694922). It is associated with the ADPRS gene. Search below for active recruiting clinical trials from ClinicalTrials.gov, or visit the Orphanet expert page for specialist centres, natural history studies, and patient registries.
Clinical Trial Eligibility Tips
What to know before applying to Childhood-onset stress-induced neurodegenerative ataxia-seizure syndrome trials.
Search ClinicalTrials.gov for "Childhood-onset stress-induced neurodegenerative ataxia-seizure syndrome" or filter by Orphanet code ORPHA:694922 to find disease-specific studies.
Ask your specialist to refer you to a Centre of Expertise — Orphanet lists all accredited centres for this condition worldwide.
Natural history studies and patient registries often enrol before drug trials open — contact the Orphanet patient community first.
Patient Resources
Find recruiting Childhood-onset stress-induced neurodegenerative ataxia-seizure syndrome trials
Search 500,000+ studies from ClinicalTrials.gov, filtered for Childhood-onset stress-induced neurodegenerative ataxia-seizure syndrome. Updated daily.